{
    "clinical_study": {
        "@rank": "72015", 
        "arm_group": [
            {
                "arm_group_label": "Zoladex", 
                "arm_group_type": "Active Comparator", 
                "description": "After surgical vaporization of endometriosis patients are treated with Zoladex for 3 months."
            }, 
            {
                "arm_group_label": "vaporization only", 
                "arm_group_type": "No Intervention", 
                "description": "Surgical vaporization of the endometriosis is done and patients start IVF without additional treatment."
            }
        ], 
        "brief_summary": {
            "textblock": "In this study of endometriosis patients we compare a common treatment of surgical therapy\n      and medical treatment for 3 months (Zoladex)with patients receiving only surgical therapy.\n      In both cases they immediately start IVF treatment."
        }, 
        "brief_title": "Pregnancy Outcome After IVF/ICSI in Endometriosis Patients Stage I and II", 
        "condition": [
            "Infertility", 
            "Endometriosis Stage I and II"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Endometriosis", 
                "Infertility"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  1,2, 3e IVF cycle\n\n          -  endometriosis stage I and II\n\n          -  <38 years old\n\n        Exclusion Criteria:\n\n          -  endometriosis cysts\n\n          -  uterine pathology\n\n          -  endocrinological diseases and problems"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "38 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "120", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 23, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01682642", 
            "org_study_id": "2012-000784-25"
        }, 
        "intervention": {
            "arm_group_label": "Zoladex", 
            "description": "after surgical vaporization patients are treated with Zoladex for 3 months", 
            "intervention_name": "Zoladex", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Goserelin"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "endometriosis", 
            "pregnancy", 
            "IVF/ICSI"
        ], 
        "lastchanged_date": "September 7, 2012", 
        "location": {
            "contact": {
                "email": "wim.decleer@janpalfijngent.be", 
                "last_name": "Wim Decleer, gynecologist", 
                "phone": "0032 9 2243024"
            }, 
            "contact_backup": {
                "email": "ivf.centrum@janpalfijngent.be", 
                "phone": "0032 9 2248850"
            }, 
            "facility": {
                "address": {
                    "city": "Gent", 
                    "country": "Belgium", 
                    "state": "Oost-vlaanderen", 
                    "zip": "9000"
                }, 
                "name": "AZ Jan Palfijn"
            }, 
            "investigator": {
                "last_name": "Wim Decleer, gynecologist", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Belgium"
        }, 
        "number_of_arms": "2", 
        "official_title": "Pregnancy Outcome After IVF/ICSI in Endometriosis Associated Tubal Factor Infertility in Endometriosis Stage I and II. Comparison of Results of IVF After Surgical Therapy Only or After Surgical Vaporisation Associated With Medical Therapy. A Prospective Randomized Study.", 
        "overall_contact": {
            "email": "wim.decleer@janpalfijngent.be", 
            "last_name": "Wim Decleer, gynecologist", 
            "phone": "0032 9 3259220"
        }, 
        "overall_contact_backup": {
            "email": "ivf.studie@janpalfijngent.be", 
            "last_name": "Paul Devroey, professor", 
            "phone": "0032 9 2248070"
        }, 
        "overall_official": {
            "affiliation": "IVF Centrum Jan Palfijn Gent", 
            "last_name": "Wim Decleer, gynecologist", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Belgium: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "September 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "laboratory follow up of the fertilized egg during the first 24h", 
                "measure": "2 PN fertilization", 
                "safety_issue": "No", 
                "time_frame": "24 hours after ICSI"
            }, 
            {
                "description": "The development of the embryo during the first 3 to 5 days after fertilization.", 
                "measure": "embryo quality", 
                "safety_issue": "No", 
                "time_frame": "3 to 5 days after egg retrieval"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01682642"
        }, 
        "responsible_party": {
            "investigator_affiliation": "AZ Jan Palfijn Gent", 
            "investigator_full_name": "Dr. Decleer Wim", 
            "investigator_title": "gynecologist", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "The number of ongoing pregnancies obtained wich still is the most important issue for the patients.", 
            "measure": "pregnancy rate", 
            "safety_issue": "No", 
            "time_frame": "12 weeks"
        }, 
        "source": "AZ Jan Palfijn Gent", 
        "sponsors": {
            "collaborator": {
                "agency": "Onze Lieve Vrouw  Hospital", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "AZ Jan Palfijn Gent", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "September 2012"
    }
}